VERACYTE INC (VCYT) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:VCYT • US92337F1075

34.86 USD
-1.24 (-3.43%)
At close: Feb 5, 2026
34.86 USD
0 (0%)
After Hours: 2/5/2026, 8:01:24 PM
Fundamental Rating

6

Overall VCYT gets a fundamental rating of 6 out of 10. We evaluated VCYT against 524 industry peers in the Biotechnology industry. VCYT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. VCYT is not overvalued while it is showing excellent growth. This is an interesting combination. This makes VCYT very considerable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • VCYT had positive earnings in the past year.
  • In the past year VCYT had a positive cash flow from operations.
  • VCYT had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: VCYT reported negative operating cash flow in multiple years.
VCYT Yearly Net Income VS EBIT VS OCF VS FCFVCYT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

  • With an excellent Return On Assets value of 2.22%, VCYT belongs to the best of the industry, outperforming 89.31% of the companies in the same industry.
  • VCYT has a better Return On Equity (2.41%) than 90.27% of its industry peers.
  • With an excellent Return On Invested Capital value of 2.93%, VCYT belongs to the best of the industry, outperforming 90.08% of the companies in the same industry.
Industry RankSector Rank
ROA 2.22%
ROE 2.41%
ROIC 2.93%
ROA(3y)-2.66%
ROA(5y)-4.4%
ROE(3y)-2.83%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
VCYT Yearly ROA, ROE, ROICVCYT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • The Profit Margin of VCYT (6.12%) is better than 90.08% of its industry peers.
  • The Operating Margin of VCYT (9.70%) is better than 91.60% of its industry peers.
  • The Gross Margin of VCYT (68.53%) is better than 81.11% of its industry peers.
  • In the last couple of years the Gross Margin of VCYT has remained more or less at the same level.
Industry RankSector Rank
OM 9.7%
PM (TTM) 6.12%
GM 68.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
VCYT Yearly Profit, Operating, Gross MarginsVCYT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VCYT is destroying value.
  • The number of shares outstanding for VCYT has been increased compared to 1 year ago.
  • Compared to 5 years ago, VCYT has more shares outstanding
  • There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VCYT Yearly Shares OutstandingVCYT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
VCYT Yearly Total Debt VS Total AssetsVCYT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • VCYT has an Altman-Z score of 15.39. This indicates that VCYT is financially healthy and has little risk of bankruptcy at the moment.
  • VCYT has a better Altman-Z score (15.39) than 87.40% of its industry peers.
  • VCYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 15.39
ROIC/WACC0.33
WACC8.93%
VCYT Yearly LT Debt VS Equity VS FCFVCYT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 6.23 indicates that VCYT has no problem at all paying its short term obligations.
  • VCYT's Current ratio of 6.23 is fine compared to the rest of the industry. VCYT outperforms 63.74% of its industry peers.
  • VCYT has a Quick Ratio of 5.94. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of VCYT (5.94) is better than 63.17% of its industry peers.
Industry RankSector Rank
Current Ratio 6.23
Quick Ratio 5.94
VCYT Yearly Current Assets VS Current LiabilitesVCYT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • VCYT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 353.33%, which is quite impressive.
  • The Revenue has grown by 16.41% in the past year. This is quite good.
  • The Revenue has been growing by 29.93% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%

3.2 Future

  • VCYT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 51.21% yearly.
  • The Revenue is expected to grow by 11.52% on average over the next years. This is quite good.
EPS Next Y79.07%
EPS Next 2Y88.85%
EPS Next 3Y64.96%
EPS Next 5Y51.21%
Revenue Next Year14.79%
Revenue Next 2Y13.07%
Revenue Next 3Y12.72%
Revenue Next 5Y11.52%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
VCYT Yearly Revenue VS EstimatesVCYT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
VCYT Yearly EPS VS EstimatesVCYT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 -1 2

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 91.74, VCYT can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, VCYT is valued cheaply inside the industry as 89.69% of the companies are valued more expensively.
  • VCYT is valuated expensively when we compare the Price/Earnings ratio to 27.67, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 32.58, VCYT can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, VCYT is valued cheaply inside the industry as 91.60% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.20, VCYT is valued at the same level.
Industry RankSector Rank
PE 91.74
Fwd PE 32.58
VCYT Price Earnings VS Forward Price EarningsVCYT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • 92.37% of the companies in the same industry are more expensive than VCYT, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, VCYT is valued cheaply inside the industry as 94.08% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 28.13
EV/EBITDA 33.34
VCYT Per share dataVCYT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of VCYT may justify a higher PE ratio.
  • VCYT's earnings are expected to grow with 64.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.16
PEG (5Y)N/A
EPS Next 2Y88.85%
EPS Next 3Y64.96%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for VCYT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VERACYTE INC

NASDAQ:VCYT (2/5/2026, 8:01:24 PM)

After market: 34.86 0 (0%)

34.86

-1.24 (-3.43%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-04
Earnings (Next)02-23
Inst Owners114.83%
Inst Owner Change-2.01%
Ins Owners0.42%
Ins Owner Change-3.94%
Market Cap2.76B
Revenue(TTM)495.14M
Net Income(TTM)30.31M
Analysts82.11
Price Target49.7 (42.57%)
Short Float %6.58%
Short Ratio6.26
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.65%
Min EPS beat(2)-110.32%
Max EPS beat(2)79.03%
EPS beat(4)2
Avg EPS beat(4)-1.91%
Min EPS beat(4)-110.32%
Max EPS beat(4)79.03%
EPS beat(8)5
Avg EPS beat(8)108.97%
EPS beat(12)8
Avg EPS beat(12)67.3%
EPS beat(16)12
Avg EPS beat(16)58.01%
Revenue beat(2)2
Avg Revenue beat(2)4.54%
Min Revenue beat(2)3.31%
Max Revenue beat(2)5.76%
Revenue beat(4)3
Avg Revenue beat(4)2.42%
Min Revenue beat(4)-0.39%
Max Revenue beat(4)5.76%
Revenue beat(8)7
Avg Revenue beat(8)4.03%
Revenue beat(12)11
Avg Revenue beat(12)4.6%
Revenue beat(16)15
Avg Revenue beat(16)5.32%
PT rev (1m)0.75%
PT rev (3m)15.74%
EPS NQ rev (1m)3.75%
EPS NQ rev (3m)12.16%
EPS NY rev (1m)1.28%
EPS NY rev (3m)42.34%
Revenue NQ rev (1m)0.98%
Revenue NQ rev (3m)1.52%
Revenue NY rev (1m)0.26%
Revenue NY rev (3m)1.73%
Valuation
Industry RankSector Rank
PE 91.74
Fwd PE 32.58
P/S 5.57
P/FCF 28.13
P/OCF 25.58
P/B 2.19
P/tB 6.92
EV/EBITDA 33.34
EPS(TTM)0.38
EY1.09%
EPS(NY)1.07
Fwd EY3.07%
FCF(TTM)1.24
FCFY3.56%
OCF(TTM)1.36
OCFY3.91%
SpS6.26
BVpS15.91
TBVpS5.04
PEG (NY)1.16
PEG (5Y)N/A
Graham Number11.66
Profitability
Industry RankSector Rank
ROA 2.22%
ROE 2.41%
ROCE 3.71%
ROIC 2.93%
ROICexc 4.08%
ROICexgc 54.52%
OM 9.7%
PM (TTM) 6.12%
GM 68.53%
FCFM 19.79%
ROA(3y)-2.66%
ROA(5y)-4.4%
ROE(3y)-2.83%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
F-Score8
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 44.07%
Cap/Sales 1.97%
Interest Coverage 250
Cash Conversion 153.6%
Profit Quality 323.21%
Current Ratio 6.23
Quick Ratio 5.94
Altman-Z 15.39
F-Score8
WACC8.93%
ROIC/WACC0.33
Cap/Depr(3y)39.24%
Cap/Depr(5y)36.19%
Cap/Sales(3y)2.72%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
EPS Next Y79.07%
EPS Next 2Y88.85%
EPS Next 3Y64.96%
EPS Next 5Y51.21%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%
Revenue Next Year14.79%
Revenue Next 2Y13.07%
Revenue Next 3Y12.72%
Revenue Next 5Y11.52%
EBIT growth 1Y427.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year320.9%
EBIT Next 3Y74.34%
EBIT Next 5Y48.27%
FCF growth 1Y236.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y180.39%
OCF growth 3YN/A
OCF growth 5YN/A

VERACYTE INC / VCYT FAQ

What is the fundamental rating for VCYT stock?

ChartMill assigns a fundamental rating of 6 / 10 to VCYT.


What is the valuation status of VERACYTE INC (VCYT) stock?

ChartMill assigns a valuation rating of 6 / 10 to VERACYTE INC (VCYT). This can be considered as Fairly Valued.


How profitable is VERACYTE INC (VCYT) stock?

VERACYTE INC (VCYT) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for VCYT stock?

The Price/Earnings (PE) ratio for VERACYTE INC (VCYT) is 91.74 and the Price/Book (PB) ratio is 2.19.


What is the financial health of VERACYTE INC (VCYT) stock?

The financial health rating of VERACYTE INC (VCYT) is 8 / 10.